Abstract: The invention provides methods and systems for evaluating a fluid transfer event between a parenteral fluid delivery and a patient. The evaluation of the fluid transfer event can be prospective real-time and/or historic, as desired, and take a variety of different formats.
Abstract: The invention provides a receiver associated with a body, e.g., located inside or within close proximity to a body, configured to receive and decode a signal from an in vivo transmitter which located inside the body. Signal receivers of the invention provide for accurate signal decoding of a low-level signal, even in the presence of significant noise, using a small-scale chip, e.g., where the chip consumes very low power. Also provided are systems that include the receivers, as well as methods of using the same.
Type:
Grant
Filed:
March 6, 2014
Date of Patent:
July 14, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Lawrence Arne, Kit Yee Au-Yeung, Kenneth C. Crandall, Timothy Robertson
Abstract: Aspects of the invention include multi-mode communication ingestible event marker devices. Ingestible event marker devices of the invention include an ingestible component comprising a conductive communication module and at least one additional non-conductive communication module. The non-conductive communication module may be integrated with the ingestible component or at least a portion or all of the non-conductive communication module may be associated with a packaging component of the ingestible event marker device. Additional aspects of the invention include systems that include the devices and one or more receivers, as well as methods of using the same.
Abstract: A system and method are provided for securing an ingestible electronic device to a pharmaceutical product without damaging the ingestible electronic device. The product includes the ingestible electronic device being placed on the product in accordance with one aspect of the present invention. In accordance with another aspect of the present invention, the ingestible electronic device is placed inside the product. Various embodiments are disclosed in accordance with the present invention for protecting and/or coating of the electronic marker as well as securing the ingestible electronic device onto the product.
Type:
Application
Filed:
May 27, 2014
Publication date:
April 23, 2015
Applicant:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Robert Duck, Timothy Robertson, Benedict Costello
Abstract: A device for gathering data has first and second electrodes. The first electrode is coupled to a surface of interest, and the second electrode is coupled to “everything else” or “the air”. The first electrode is shielded from the second, and from most sources of parasitic capacitance, by a shield that is driven by an active driver that drives the shield to track, and ideally to match, the instantaneous potential of the electrode. The second electrode is likewise shielded in a similar way from most sources of parasitic capacitance. These shields likewise help to limit the extent to which RFI from the device electronics couples with either of the electrodes. In this way the sensing device achieves a markedly better signal-to-noise ratio at frequency bands of interest.
Type:
Grant
Filed:
January 28, 2011
Date of Patent:
April 21, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Mark Zdeblick, James Hutchison, Lawrence Arne
Abstract: Sensing is carried out from locations considerably removed from the stomach. Cooperating sensor electronics are placed at each of two wrists of the patient. The potential discomfort and inconvenience of an abdominal patch are reduced or eliminated, and alternative power sources become available.
Abstract: Virtual dipole signal amplification for in-body devices, such as implantable and ingestible devices, is provided. Aspects of the in-body deployable antennas of the invention include antennas configured to go from a first configuration to a second configuration following placement in a living body, e.g., via ingestion or implantation. Embodiments of the in-body devices are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
Type:
Grant
Filed:
September 25, 2008
Date of Patent:
February 24, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Benedict James Costello, Timothy L. Robertson, Maria Casillas Holen
Abstract: Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.
Type:
Grant
Filed:
February 14, 2008
Date of Patent:
February 17, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Timothy Robertson, Eric Snyder, Brad Cozad
Abstract: Methods, systems and compositions that allow for treating a patient according to a patient customized therapeutic regimen are provided. Embodiments of the invention include obtaining dosage administration information from a patient and using the same to tailor a therapeutic regimen for the patient. Embodiments of the invention further include preparing and forwarding to the patient physical pharmaceutical dosages based on the customized therapeutic regimen.
Type:
Grant
Filed:
May 2, 2007
Date of Patent:
February 17, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Mark J. Zdeblick, Andrew Thompson, George M. Savage
Abstract: Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials.
Type:
Grant
Filed:
July 2, 2013
Date of Patent:
February 10, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Gregory Moon, Kityee Au-Yeung, Robert Duck, Maria Casillas Holen
Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
Type:
Grant
Filed:
October 25, 2007
Date of Patent:
February 3, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
Abstract: Multi-directional transmitters for in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body multi-direction transmitters of the invention include signal transmitters configured to transmit an identifying signal in at least two different directions in an x-y plane. Embodiments of the in-body devices are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
Type:
Grant
Filed:
March 7, 2008
Date of Patent:
January 13, 2015
Assignee:
Proteus Digital Health, Inc.
Inventors:
Olivier Colliou, Timothy Robertson, Mark Zdeblick
Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can also measure the conditions of the environment surrounding the system.
Type:
Grant
Filed:
July 11, 2011
Date of Patent:
December 16, 2014
Assignee:
Proteus Digital Health, Inc.
Inventors:
Jeffrey Berkman, Mark Zdeblick, Patricia Johnson, Hooman Hafezi, Jonathan Withrington
Abstract: The invention provides a receiver associated with a body, e.g., located inside or within close proximity to a body, configured to receive and decode a signal from an in vivo transmitter which located inside the body. Signal receivers of the invention provide for accurate signal decoding of a low-level signal, even in the presence of significant noise, using a small-scale chip, e.g., where the chip consumes very low power. Also provided are systems that include the receivers, as well as methods of using the same.
Type:
Application
Filed:
March 6, 2014
Publication date:
November 13, 2014
Applicant:
Proteus Digital Health, Inc.
Inventors:
Lawrence Arne, Kit Yee Au-Yeung, Kenneth C. Crandall, Timothy Robertson
Abstract: A system for tracking a product from origin to destination is disclosed. The system includes a probe that comprises two plates, a power source and a processor. The power source is controlled by the processor to produce an oscillating output at the plates. Using the oscillating voltage, the probe interrogates a device through capacitive coupling. The device includes a control unit, a memory unit, and first and second materials physically associated with the device for communication using capacitive coupling. Information associated with the device is transferred from the device to the probe through capacitive coupling between the first and second materials and the first and second plates, respectively.
Abstract: Virtual dipole signal amplification for in-body devices, such as implantable and ingestible devices, is provided. Aspects of the in-body deployable antennas of the invention include antennas configured to go from a first configuration to a second configuration following placement in a living body, e.g., via ingestion or implantation. Embodiments of the in-body devices are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.
Type:
Application
Filed:
January 22, 2014
Publication date:
October 16, 2014
Applicant:
Proteus Digital Health, Inc.
Inventors:
Hooman Hafezi, Benedict Costello, Timothy Robertson, Maria Casillas Holen
Abstract: Ingestible event marker systems that include an ingestible event marker (i.e., an IEM) and a personal signal receiver are provided. Embodiments of the IEM include an identifier, which may or may not be present in a physiologically acceptable carrier. The identifier is characterized by being activated upon contact with a target internal physiological site of a body, such as digestive tract internal target site. The personal signal receiver is configured to be associated with a physiological location, e.g., inside of or on the body, and to receive a signal the IEM. During use, the IEM broadcasts a signal which is received by the personal signal receiver.
Type:
Grant
Filed:
February 1, 2008
Date of Patent:
October 14, 2014
Assignee:
Proteus Digital Health, Inc.
Inventors:
Timothy Robertson, George Savage, Mark Zdeblick, Yashar Behzadi, Benedict Costello, Jeremy Frank, Hooman Hafezi, Tariq Haniff, David O'Reilly